Skip to content

Checking safety and efficacy of product

To assess the in-vivo safety and efficacy of a Hair Care Regime in terms of reduction in dandruff on healthy human subjects - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064373
Enrollment
36
Registered
2024-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Beauty Garage Scalp Sense Soothing Shampoo: It is a part of Regime. The product is applied on whole scalp and shafts , once in two weeks for a period of 28 days. Intervention2: Beauty G

Sponsors

Beauty Garage India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian / Asian male and female subjects. 2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) 3.Skin & scalp is healthy on the studied anatomic unit 4.Having dry scalp & Having moderate to severe dandruff

Exclusion criteria

Exclusion criteria: 1.For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2.Having refused to give her assent by not signing the consent form. 3.Taking part in another study is liable to interfere with this study. 4.Having chronic dermatosis liable to modify the cutaneous reactivity on the tested area. 5.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 6.Having a progressive asthma (either under treatment or last fit in the last 2 years) 7.Being epileptic 8.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 9.Having cutaneous hypersensitivity 10.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products 11.Following a chronic or intermittent medicinal treatment comprising any of the following products:aspirin-based products, anti-inflammatories, anti-histamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 12.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months 13.Having changed her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.

Design outcomes

Primary

MeasureTime frame
Reduction in dandruff, SafetyTimepoint: Baseline, 14 days, 28 days

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

raji@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026